Lawrence J. McQuillan
Business & Economics
More tort reform
Editor: Pennsylvania doctors and consumers should be thrilled that the number of medical-malpractice lawsuits has fallen in the commonwealth (“Insurance rates for doctors shrinking,” Nov. 16). Meaningful tort reforms — of the sort advanced by the Keystone State in the past few years — are an effective way to reduce ...
Lawrence J. McQuillan
December 3, 2008
Business & Economics
Letter: Litigation costs hurt Bay State doctors, hospitals
To the editor: Kudos for your Nov. 20 editorial on the devastating impact of rising malpractice insurance premiums and defensive medicine costs on the North Shore Birth Center and other medical facilities in Massachusetts. (“Birth Center’s problems highlight need for tort reform”). Defensive medicine is not just a problem in ...
Lawrence J. McQuillan
November 28, 2008
Business & Economics
Decision against Wyeth would clog courts
Regarding “Wyeth should win/Otherwise, a bad case will make bad law” (Editorial, Nov. 17): Your editorial on the ramifications of a ruling against Wyeth Pharmaceuticals for the U.S. health care system was right on the money, particularly regarding the potential for a torrent of frivolous and wasteful lawsuits. A decision ...
Lawrence J. McQuillan
November 26, 2008
Business & Economics
Don’t Let Tort Lawyers Undermine the Constitution
The U.S. Supreme Court just heard arguments in Wyeth v. Levine, a case with profound implications for the health of all Americans. The plaintiff, Diana Levine, was given Wyeth’s anti-nausea drug Phenergan, then on the market for 45 years. In rare instances, Phenergan can cause gangrene if it comes in ...
Lawrence J. McQuillan
November 11, 2008
Business & Economics
Court ruling could curb medical research
Wyeth properly warned doctors and patients about the risks associated with administering Phenergan (“FDA pre-emptive rule to be challenged,” Nov. 2). The FDA-approved label contained prominent warnings: “Extreme care should be exercised to avoid … inadvertent intra-arterial injection. Reports compatible with inadvertent intra-arterial injection … suggest that pain, severe chemical ...
Lawrence J. McQuillan
November 10, 2008
Business & Economics
Tort law a threat to your health?
Washington Times, November 5, 2008 Spanish Journal ((Milwaukee, WI), November 19, 2008 Floodwood Forum (Floodwood, MN), November 20, 2008 Tri-City Voice (Fremont, CA), March 18, 2009 COMMENTARY: The U.S. Supreme Court Monday heard arguments in Wyeth v. Levine, a case that could uphold a fundamental tenet of our Constitution. Or, ...
Lawrence J. McQuillan
November 5, 2008
Business & Economics
Side effects
Boston Herald, November 5, 2008 Los Angeles Times, November 8, 2008 San Francisco Examiner, November 9, 2008 Letter to the Editor The health of all Americans is at stake as the U.S. Supreme Court weighs the arguments in Wyeth vs. Levine (“U.S. court hears amputee’s case in drug suit,” Nov. ...
Lawrence J. McQuillan
November 5, 2008
Business & Economics
To dig out of the hole, N.Y. must expand economic freedom
The economic misery caused by the nation’s financial meltdown has hit New York especially hard. Since September 2007, the city’s financial sector has lost 13,400 jobs, according to the state Labor Department. An additional 65,000 financial jobs will be gone in New York and its suburbs by mid-2010, says BusinessWeek. ...
Lawrence J. McQuillan
October 29, 2008
Business & Economics
Medical Lawsuits Put Health At Risk
On Nov. 3, a day before the election, the U.S. Supreme Court hears Wyeth v. Levine, a case with profound implications for the health of all Americans. In 2000, plaintiff Diane Levine was given Wyeth’s anti-nausea drug Phenergan, then on the market for 45 years. In rare instances, as the ...
Lawrence J. McQuillan
October 24, 2008
Business & Economics
Californians Voting with Their Feet
The state government’s stifling economic policies are worsening the downturn and driving citizens elsewhere. With the implosion of its storied investment banks and the future of Wall Street in doubt, New York will suffer the effects of the financial crisis more acutely than many states. But the crisis reaches epicenters ...
Lawrence J. McQuillan
October 23, 2008
More tort reform
Editor: Pennsylvania doctors and consumers should be thrilled that the number of medical-malpractice lawsuits has fallen in the commonwealth (“Insurance rates for doctors shrinking,” Nov. 16). Meaningful tort reforms — of the sort advanced by the Keystone State in the past few years — are an effective way to reduce ...
Letter: Litigation costs hurt Bay State doctors, hospitals
To the editor: Kudos for your Nov. 20 editorial on the devastating impact of rising malpractice insurance premiums and defensive medicine costs on the North Shore Birth Center and other medical facilities in Massachusetts. (“Birth Center’s problems highlight need for tort reform”). Defensive medicine is not just a problem in ...
Decision against Wyeth would clog courts
Regarding “Wyeth should win/Otherwise, a bad case will make bad law” (Editorial, Nov. 17): Your editorial on the ramifications of a ruling against Wyeth Pharmaceuticals for the U.S. health care system was right on the money, particularly regarding the potential for a torrent of frivolous and wasteful lawsuits. A decision ...
Don’t Let Tort Lawyers Undermine the Constitution
The U.S. Supreme Court just heard arguments in Wyeth v. Levine, a case with profound implications for the health of all Americans. The plaintiff, Diana Levine, was given Wyeth’s anti-nausea drug Phenergan, then on the market for 45 years. In rare instances, Phenergan can cause gangrene if it comes in ...
Court ruling could curb medical research
Wyeth properly warned doctors and patients about the risks associated with administering Phenergan (“FDA pre-emptive rule to be challenged,” Nov. 2). The FDA-approved label contained prominent warnings: “Extreme care should be exercised to avoid … inadvertent intra-arterial injection. Reports compatible with inadvertent intra-arterial injection … suggest that pain, severe chemical ...
Tort law a threat to your health?
Washington Times, November 5, 2008 Spanish Journal ((Milwaukee, WI), November 19, 2008 Floodwood Forum (Floodwood, MN), November 20, 2008 Tri-City Voice (Fremont, CA), March 18, 2009 COMMENTARY: The U.S. Supreme Court Monday heard arguments in Wyeth v. Levine, a case that could uphold a fundamental tenet of our Constitution. Or, ...
Side effects
Boston Herald, November 5, 2008 Los Angeles Times, November 8, 2008 San Francisco Examiner, November 9, 2008 Letter to the Editor The health of all Americans is at stake as the U.S. Supreme Court weighs the arguments in Wyeth vs. Levine (“U.S. court hears amputee’s case in drug suit,” Nov. ...
To dig out of the hole, N.Y. must expand economic freedom
The economic misery caused by the nation’s financial meltdown has hit New York especially hard. Since September 2007, the city’s financial sector has lost 13,400 jobs, according to the state Labor Department. An additional 65,000 financial jobs will be gone in New York and its suburbs by mid-2010, says BusinessWeek. ...
Medical Lawsuits Put Health At Risk
On Nov. 3, a day before the election, the U.S. Supreme Court hears Wyeth v. Levine, a case with profound implications for the health of all Americans. In 2000, plaintiff Diane Levine was given Wyeth’s anti-nausea drug Phenergan, then on the market for 45 years. In rare instances, as the ...
Californians Voting with Their Feet
The state government’s stifling economic policies are worsening the downturn and driving citizens elsewhere. With the implosion of its storied investment banks and the future of Wall Street in doubt, New York will suffer the effects of the financial crisis more acutely than many states. But the crisis reaches epicenters ...